The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
Abstract
Objective: To develop practical recommendations for the use of low-molecular-weight heparins (LMWHs) as prophylaxis and treatment of venous thromboembolism and acute coronary syndromes in patients with impaired renal function or obesity. Data Sources: Multiple MEDLINE searches were performed (November 2008) to identify studies for inclusion, using a comprehensive list of search terms including, but not limited to, LMWH, enoxaparin, dalteparin, tinzaparin, obesity, weight, renal, kidney, elderly, monitoring, and anti-Xa. Study Selection And Data Extraction: Only articles published in English that were relevant for this review were included. Data Synthesis: In the majority of patients, standardized prophylaxis or treatment doses of LMWHs can be used without the need for monitoring and adjusting regimens. For patients with severe renal impairment (estimated creatinine clearance [CrCl] <30 mL/min), doses of some LMWHs should be adjusted or unfractionated heparin should be used instead. CrCl should be estimated using the Cockcroft-Gault method. Differences are noted in the degree of accumulation of various LMWHs in patients with moderate-to-severe renal impairment, and thus, the degree of dose adjustment may differ among the various LMWHs. Increasing the prophylactic doses of LMWH may be appropriate in morbidly obese patients (body mass index ≥40 kg/m 2). The use of total body weight is appropriate for therapeutic doses of LMWH in obese patients. Laboratory monitoring of the anticoagulation effect of LMWHs is generally not necessary, but should be considered in patients with morbid obesity (weight >190 kg), those with severe renal impairment, and those with moderate renal impairment with prolonged (>10 days) LMWH use. When anti-Xa activity is monitored, it should be determined using a chromogenic method and a calibration curve based on the LMWH used. Conclusions: Additional data are needed for specific dose guiding in obese and renally impaired patients, who are often excluded from larger clinical trials. Practice recommendations are made based on available evidence and authors' clinical opinions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Samama, M. M., Cohen, A. T., Darmon, J.-Y., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Nguyen, H., Olsson, C.-G., Turpie, A. G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411103 · Cited by 1,584
Antman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.188209 · Cited by 1,562
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.013 · Cited by 1,510
Cohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G. G., Fromell, G. J., Goodman, S., Langer, A., Califf, R. M., Fox, K. A. A., Premmereur, J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370702 · Cited by 1,424
Antman, E. M., McCabe, C. H., Gurfinkel, E. P., Turpie, A. G. G., Bernink, P. J. L. M., Salein, D., Bayes de Luna, A., Fox, K., Lablanche, J.-M., Radley, D., et al. (1999) · Circulation · doi:10.1161/01.cir.100.15.1593 · Cited by 1,052
Leizorovicz, A., Cohen, A. T., Turpie, A. G. G., Olsson, C.-G., Vaitkus, P. T., & Goldhaber, S. Z. (2004) · Circulation · doi:10.1161/01.cir.0000138928.83266.24 · Cited by 955
Dries, D. L., Exner, D. V., Domanski, M. J., Greenberg, B., & Stevenson, L. W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00608-7 · Cited by 879
Simonneau, G., Sors, H., Charbonnier, B., Page, Y., Laaban, J.-P., Azarian, R., Laurent, M., Hirsch, J.-L., Ferrari, E., Bosson, J.-L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371002 · Cited by 782
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
Poggio, E. D., Wang, X., Greene, T., Van Lente, F., & Hall, P. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060447 · Cited by 644
Eyer, M. M., Amama, M. I. S., Lexander, A., Ohen, T. H. C., Ean, J., Armon, V. D., Esjardins, L. O. D., Ldor, A. M. E., Anbon, C. H. J., Eizorovicz, A. L. L., et al. (1999) · Cited by 623
Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., López-Sendón, J. L., Guneri, S., Jiang, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060898 · Cited by 609
Klein, W., Buchwald, A., Hillis, S. E., Monrad, S., Sanz, G., Turpie, A. G. G., van der Meer, J., Olaisson, E., Undeland, S., & Ludwig, K. (1997) · Circulation · doi:10.1161/01.cir.96.1.61 · Cited by 526
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
Lim, W., Dentali, F., Eikelboom, J. W., & Crowther, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-9-200605020-00011 · Cited by 443
Deitcher, S. R., Kessler, C. M., Merli, G., Rigas, J. R., Lyons, R. M., & Fareed, J. (2006) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029606293692 · Cited by 392
Wallentin, L., Goldstein, P., Armstrong, P. W., Granger, C. B., Adgey, A. A. J., Arntz, H. R., Bogaerts, K., Danays, T., Lindahl, B., Mäkijärvi, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000081659.72985.a8 · Cited by 384
Merli, G., Spiro, T. E., Olsson, C.-G., Abildgaard, U., Davidson, B. L., Eldor, A., Elias, D., Grigg, A., Musset, D., Rodgers, G. M., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00009 · Cited by 362
Low-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC)
Swahn, E., & Wallentin, L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00486-4 · Cited by 354
Wallentin, L. C., Swahn, E., Kontny, F. P., Husted, S., Lagerqvist, B., Ståhle, E., Jd, N., Dellborg, M., Geiran, O. R., Grande, P., et al. (1999) · PubMed · Cited by 338
Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly Patients
Swedko, P. J., Clark, H. D., Paramsothy, K., & Akbari, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.3.356 · Cited by 323
Scholten, D. J., Hoedema, R. M., & Scholten, S. E. (2002) · Obesity Surgery · doi:10.1381/096089202321144522 · Cited by 274
Hsu, C.-Y., Vittinghoff, E., Lin, F., & Shlipak, M. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-2-200407200-00007 · Cited by 266
Hull, R. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2199 · Cited by 262
Laposata, M., Green, D., Cott, E. M. V., Barrowcliffe, T. W., Goodnight, S. H., & Sosolik, R. C. (1998) · PubMed · Cited by 249
Nieuwenhuis, H., Albada, J., Banga, J., & Sixma, J. (1991) · Blood · doi:10.1182/blood.v78.9.2337.2337 · Cited by 226
Prolonged Enoxaparin Therapy to Prevent Venous Thromboembolism After Primary Hip or Knee Replacement
Comp, P. C., Spiro, T. E., Friedman, R. J., Whitsett, T. L., Johnson, G. J., Gardiner, G. A., Landon, G. C., & Jové, M. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200103000-00004 · Cited by 221
Antithrombotic Therapy in Children
Monagle, P., Michelson, A. D., Bovill, E., & Andrew, M. (2001) · Chest · doi:10.1378/chest.119.1_suppl.344s · Cited by 220
Low-Molecular-Weight Heparin vs Heparin in the Treatment of Patients With Pulmonary Embolism
Hull, R. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.229 · Cited by 200
Hamad, G. G., & Choban, P. S. (2005) · Obesity Surgery · doi:10.1381/096089205774859245 · Cited by 199
The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers
Sanderink, G., Le Liboux, A., Jariwala, N., Harding, N., Ozoux, M., Shukla, U., Montay, G., Boutouyrie, B., & Miro, A. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127114 · Cited by 186
Fehrman‐Ekholm, I., & Skeppholm, L. (2004) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590310015750 · Cited by 175
Lim, W., Cook, D. J., & Crowther, M. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145014.80714.35 · Cited by 168
Becker, R. C., Spencer, F. A., Gibson, M., Rush, J. E., Sanderink, G., Murphy, S. A., Ball, S. P., & Antman, E. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120774 · Cited by 166
Montalescot, G., Collet, J. P., Tanguy, M. L., Ankri, A., Payot, L., Dumaine, R., Choussat, R., Beygui, F., Gallois, V., & Thomas, D. (2004) · Circulation · doi:10.1161/01.cir.0000136830.65073.c7 · Cited by 163
Borkgren-Okonek, M. J., Hart, R. W., Pantano, J. E., Rantis, P. C., Guske, P. J., Kane, J. M., Gordon, N., & Sambol, N. C. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.11.010 · Cited by 155
Douketis, J. D., Cook, D., Meade, M., Guyatt, G., Geerts, W., Skrobik, Y., Albert, M., Granton, J., Hébert, P., Pagliarello, G., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.16.1805 · Cited by 155
Aghassarian, M., Drouet, L. O., Sollier, C. B. D., Lacut, K., Heilmann, J., Mottier, D., Bergmann, J., & Mahé, I. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-09-0513 · Cited by 129
Iampietro, R., Woolley, A. M., Preston, F. E., & Kitchen, S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614377 · Cited by 112
Anticoagulation in Hospitalized Patients With Renal Insufficiency
Thorevska, N. Y., Amoateng‐Adjepong, Y., Sabahi, R., Schiopescu, I., Salloum, A., Muralidharan, V., & Manthous, C. A. (2004) · CHEST Journal · doi:10.1378/chest.125.3.856 · Cited by 109
Fox, K. A. A., Bassand, J., Mehta, S. R., Wallentin, L. C., Théroux, P., Piegas, L. S., Valentin, V., Moccetti, T., Chrolavicius, S., Afzal, R., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-5-200709040-00005 · Cited by 109
The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial
Fox, K. A. A., Antman, E. M., Montalescot, G., Agewall, S., SomaRaju, B., Verheugt, F. W. A., López-Sendón, J. L., Hod, H., Murphy, S. A., & D, E. B. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.049 · Cited by 101
Simone, E. P., Madan, A. K., Tichansky, D. S., Kuhl, D. A., & Lee, M. D. (2008) · Surgical Endoscopy · doi:10.1007/s00464-008-9997-6 · Cited by 99
White, H. D., Braunwald, E., Murphy, S. A., Jacob, A., Gotcheva, N. N., Polonetsky, L. Z., & Antman, E. M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm081 · Cited by 97
Reversing anticoagulants both old and new.
Warkentin, T. E., & Crowther, M. A. (2002) · PubMed · Cited by 96
Wilson, J.-A. S., Wilbur, K., Burton, E., & Anderson, D. R. (2001) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000048043 · Cited by 95
Barba, R., Marco, J., Martín-Alvarez, H., Rondón, P., Fernández‐Capitán, C., García-Bragado, F., & Monréal, M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01304.x · Cited by 90
Contemporary Laboratory Monitoring of Low Molecular Weight Heparins
Samama, M. M., & Poller, L. (1995) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30347-0 · Cited by 83
Collet, J., Montalescot, G., Agnelli, G., de Werf, F. V., Gurfinkel, E., López-Sendón, J. L., Laufenberg, C. V., Klutmann, M., Gowda, N., & Gulba, D. C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi337 · Cited by 79
Falgà-Tirado, C., Capdevila, J. A., Soler, S., Rey, R. R., Muñoz-Torrero, J. F. S., Gallego, P., & Monréal, M. (2007) · PubMed · Cited by 78
Kovacs, M. J., Keeney, M., MacKinnon, K., & Boyle, E. (1999) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.1999.00183.x · Cited by 75
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency
Rabbat, C. G., Cook, D. J., Crowther, M. A., McDonald, E., Clarke, F. J., Meade, M., Lee, K., & Cook, R. J. (2005) · Journal of Critical Care · doi:10.1016/j.jcrc.2005.09.009 · Cited by 75
Escalante-Tattersfield, T., Tucker, O., Fajnwaks, P., Szomstein, S., & Rosenthal, R. J. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.12.015 · Cited by 62
Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials
Collet, J., Montalescot, G., Fine, E., Golmard, J., Dalby, M. C. D., Choussat, R., Ankri, A., Dumaine, R. L., Lesty, C., Vignolles, N., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02664-5 · Cited by 58
Prophylactic and therapeutic enoxaparin during pregnancy: Indications, outcomes and monitoring
Rowan, J., McLintock, C., Taylor, R. S., & North, R. A. (2003) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1046/j.0004-8666.2003.00034.x · Cited by 52
Bruno, R., Baille, P., Retout, S., Vivier, N., Veyrat‐Follet, C., Sanderink, G., Becker, R. C., & Antman, E. M. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01904.x · Cited by 45
Kardys, C. M., Stoner, M. C., Manwaring, M. L., Barker, M., MacDonald, K. G., Pender, J. R., & Chapman, W. H. H. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.09.015 · Cited by 36
Isla, A., Rodríguez‐Gascón, A., Maynar, J., Arzuaga, A., Corral, E., Martín, A. H. S., Solinís, M. Á., & Pedraz, J. L. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.09.008 · Cited by 31
The skinny on treatment of venous thromboembolism in obesity
Spinler, S. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01342.x · Cited by 7
Cohen, M. C., Alexander, K. P., & Rao, S. V. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0182-x · Cited by 6
Cited by
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Matzke, G. R., Aronoff, G. R., Atkinson, A. J., Bennett, W. M., Decker, B. S., Eckardt, K.-U., Golper, T., Grabe, D. W., Kasiske, B., Keller, F., et al. (2011) · Kidney International · doi:10.1038/ki.2011.322 · Cited by 462
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
Cuker, A., Siegal, D. M., Crowther, M. A., & Garcia, D. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.065 · Cited by 449
Wang, Z., Frost, C., Shenker, A., & Barrett, Y. C. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0328 · Cited by 356
Upreti, V. V., Wang, J., Barrett, Y. C., Byon, W., Boyd, R. A., Pursley, J., LaCreta, F. P., & Frost, C. E. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12114 · Cited by 269
Metadata
- Authors
- Nutescu, E. A., Spinier, S. A., Wittkowsky, A., & Dager, W. E.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2009-05-19
- Volume
- 43
- Issue
- 6
- Pages
- 1064-1083
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2156074347
- Cited by
- 289
- References
- 69
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.